Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.

Identifieur interne : 004716 ( Main/Exploration ); précédent : 004715; suivant : 004717

Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.

Auteurs : RBID : pubmed:8535344

English descriptors

Abstract

Mouse macrophages purified by elutriation from thioglycollate-induced peritoneal exudate cells were labelled with indium-111-oxine and injected intravenously into mice. A substantial amount of unbound radioactivity remained in the circulation, suggesting that the radionuclide was not stably bound to the cells. Culture experiments with radiolabelled cells showed that indium-111 was released in the medium. Another cell marker, PKH-95, an iodine-125-labelled aliphatic compound insertable into the cell membrane, bound more stably than indium-111. Five minutes after injection of 125I-PKH-95-labelled macrophages, about 98% of the cells were in a non-circulating pool. It was checked that PKH-95 labelling did not compromise the viability and functions of the macrophages and that autologous erythrocytes and blood mononuclear cells labelled with PKH-95 remained in the circulation after i.v. injection. One hour after injection, 125I-PKH-95-labelled macrophages were distributed mainly in lung (36%), liver (19%) and spleen (5%). Subsequently, radioactivity decreased in the lung while increasing in liver, spleen and in an artificially induced footpad inflammation. The radioactivity accumulation in the inflammation persisted at least for 7 days. It represented a small proportion of radioactivity injected (0.2%) but was trapped very specifically in the inflammation. This raised the hypothesis that macrophages of the non-circulating pool could be released in the circulation and recruited into the inflammation with slow kinetics.

PubMed: 8535344

Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.</title>
<author>
<name sortKey="Audran, R" uniqKey="Audran R">R Audran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre régional de lutte contre le cancer, Rennes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre régional de lutte contre le cancer, Rennes</wicri:regionArea>
<placeName>
<region type="région">Région Bretagne</region>
<settlement type="city">Rennes</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Collet, B" uniqKey="Collet B">B Collet</name>
</author>
<author>
<name sortKey="Moisan, A" uniqKey="Moisan A">A Moisan</name>
</author>
<author>
<name sortKey="Toujas, L" uniqKey="Toujas L">L Toujas</name>
</author>
</titleStmt>
<publicationStmt>
<date when="1995">1995</date>
<idno type="RBID">pubmed:8535344</idno>
<idno type="pmid">8535344</idno>
<idno type="wicri:Area/Main/Corpus">004922</idno>
<idno type="wicri:Area/Main/Curation">004922</idno>
<idno type="wicri:Area/Main/Exploration">004716</idno>
</publicationStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Cell Survival</term>
<term>Cells, Cultured</term>
<term>Erythrocytes (cytology)</term>
<term>Erythrocytes (physiology)</term>
<term>Fluorescent Dyes (diagnostic use)</term>
<term>Fluorescent Dyes (pharmacokinetics)</term>
<term>Indium Radioisotopes (diagnostic use)</term>
<term>Iodine Radioisotopes (diagnostic use)</term>
<term>Kinetics</term>
<term>Lymphocytes (cytology)</term>
<term>Lymphocytes (physiology)</term>
<term>Macrophages, Peritoneal (cytology)</term>
<term>Macrophages, Peritoneal (physiology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Organic Chemicals</term>
<term>Organometallic Compounds (diagnostic use)</term>
<term>Organometallic Compounds (pharmacokinetics)</term>
<term>Oxyquinoline (analogs & derivatives)</term>
<term>Oxyquinoline (diagnostic use)</term>
<term>Oxyquinoline (pharmacokinetics)</term>
<term>Radioisotope Dilution Technique</term>
<term>Time Factors</term>
<term>Tissue Distribution</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Oxyquinoline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en">
<term>Fluorescent Dyes</term>
<term>Indium Radioisotopes</term>
<term>Iodine Radioisotopes</term>
<term>Organometallic Compounds</term>
<term>Oxyquinoline</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Erythrocytes</term>
<term>Lymphocytes</term>
<term>Macrophages, Peritoneal</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Fluorescent Dyes</term>
<term>Organometallic Compounds</term>
<term>Oxyquinoline</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Erythrocytes</term>
<term>Lymphocytes</term>
<term>Macrophages, Peritoneal</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Survival</term>
<term>Cells, Cultured</term>
<term>Kinetics</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Organic Chemicals</term>
<term>Radioisotope Dilution Technique</term>
<term>Time Factors</term>
<term>Tissue Distribution</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mouse macrophages purified by elutriation from thioglycollate-induced peritoneal exudate cells were labelled with indium-111-oxine and injected intravenously into mice. A substantial amount of unbound radioactivity remained in the circulation, suggesting that the radionuclide was not stably bound to the cells. Culture experiments with radiolabelled cells showed that indium-111 was released in the medium. Another cell marker, PKH-95, an iodine-125-labelled aliphatic compound insertable into the cell membrane, bound more stably than indium-111. Five minutes after injection of 125I-PKH-95-labelled macrophages, about 98% of the cells were in a non-circulating pool. It was checked that PKH-95 labelling did not compromise the viability and functions of the macrophages and that autologous erythrocytes and blood mononuclear cells labelled with PKH-95 remained in the circulation after i.v. injection. One hour after injection, 125I-PKH-95-labelled macrophages were distributed mainly in lung (36%), liver (19%) and spleen (5%). Subsequently, radioactivity decreased in the lung while increasing in liver, spleen and in an artificially induced footpad inflammation. The radioactivity accumulation in the inflammation persisted at least for 7 days. It represented a small proportion of radioactivity injected (0.2%) but was trapped very specifically in the inflammation. This raised the hypothesis that macrophages of the non-circulating pool could be released in the circulation and recruited into the inflammation with slow kinetics.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">8535344</PMID>
<DateCreated>
<Year>1996</Year>
<Month>02</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted>
<Year>1996</Year>
<Month>02</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0969-8051</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>22</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1995</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Nuclear medicine and biology</Title>
<ISOAbbreviation>Nucl. Med. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.</ArticleTitle>
<Pagination>
<MedlinePgn>817-21</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Mouse macrophages purified by elutriation from thioglycollate-induced peritoneal exudate cells were labelled with indium-111-oxine and injected intravenously into mice. A substantial amount of unbound radioactivity remained in the circulation, suggesting that the radionuclide was not stably bound to the cells. Culture experiments with radiolabelled cells showed that indium-111 was released in the medium. Another cell marker, PKH-95, an iodine-125-labelled aliphatic compound insertable into the cell membrane, bound more stably than indium-111. Five minutes after injection of 125I-PKH-95-labelled macrophages, about 98% of the cells were in a non-circulating pool. It was checked that PKH-95 labelling did not compromise the viability and functions of the macrophages and that autologous erythrocytes and blood mononuclear cells labelled with PKH-95 remained in the circulation after i.v. injection. One hour after injection, 125I-PKH-95-labelled macrophages were distributed mainly in lung (36%), liver (19%) and spleen (5%). Subsequently, radioactivity decreased in the lung while increasing in liver, spleen and in an artificially induced footpad inflammation. The radioactivity accumulation in the inflammation persisted at least for 7 days. It represented a small proportion of radioactivity injected (0.2%) but was trapped very specifically in the inflammation. This raised the hypothesis that macrophages of the non-circulating pool could be released in the circulation and recruited into the inflammation with slow kinetics.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Audran</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<Affiliation>Centre régional de lutte contre le cancer, Rennes, France.</Affiliation>
</Author>
<Author ValidYN="Y">
<LastName>Collet</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moisan</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Toujas</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>ENGLAND</Country>
<MedlineTA>Nucl Med Biol</MedlineTA>
<NlmUniqueID>9304420</NlmUniqueID>
<ISSNLinking>0969-8051</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Fluorescent Dyes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Indium Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Iodine Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Organic Chemicals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Organometallic Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>PKH 95</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>14514-42-2</RegistryNumber>
<NameOfSubstance>indium oxine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>5UTX5635HP</RegistryNumber>
<NameOfSubstance>Oxyquinoline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="N">cytology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fluorescent Dyes</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnostic use</QualifierName>
<QualifierName MajorTopicYN="N">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Indium Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iodine Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N">cytology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Macrophages, Peritoneal</DescriptorName>
<QualifierName MajorTopicYN="N">cytology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organic Chemicals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organometallic Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnostic use</QualifierName>
<QualifierName MajorTopicYN="N">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxyquinoline</DescriptorName>
<QualifierName MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
<QualifierName MajorTopicYN="N">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radioisotope Dilution Technique</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Distribution</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1995</Year>
<Month>8</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1995</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1995</Year>
<Month>8</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">8535344</ArticleId>
<ArticleId IdType="pii">0969-8051(95)00013-N</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004716 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004716 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:8535344
   |texte=   Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:8535344" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a IndiumV2 

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024